Standout Papers

Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR ... 2009 2026 2014 2020 1.7k
  1. Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group (2009)
    Anja Rinke, Hans‐Helge Müller et al. Journal of Clinical Oncology

Immediate Impact

2 by Nobel laureates 27 from Science/Nature 63 standout
Sub-graph 1 of 21

Citing Papers

[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
2024 Standout
Recent Advances in Contrast-Enhanced Photoacoustic Imaging: Overcoming the Physical and Practical Challenges
2023 Standout
23 intermediate papers

Works of Peter Barth being referenced

Multispectral optoacoustic tomography of the human breast: characterisation of healthy tissue and malignant lesions using a hybrid ultrasound-optoacoustic approach
2017
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
2009 Standout
and 3 more

Author Peers

Author Last Decade Papers Cites
Peter Barth 880 1224 2825 2299 1579 148 6.1k
Fausto Sessa 1067 2132 4159 2448 1070 201 7.5k
Bita Esmaeli 619 1758 3616 1785 657 268 7.8k
Kiyoshi Mukai 1218 1302 1614 886 1009 162 5.7k
Philipp Ströbel 1392 1827 1827 892 2755 276 7.3k
Jiří Bártek 657 934 1958 860 1335 167 6.2k
Swee T. Tan 519 2166 1482 699 938 186 5.1k
Michael N. Koss 2541 1508 1940 1268 810 121 6.5k
Jed G. Nuchtern 880 1685 2151 657 1880 152 6.9k
Nobuaki Funata 750 2213 1030 1477 637 139 5.5k
Alberto Garaventa 948 1139 1625 963 4289 244 6.8k

All Works

Loading papers...

Rankless by CCL
2026